Search for: "Mylan Pharmaceuticals"
Results 421 - 440
of 739
Sort by Relevance
|
Sort by Date
13 Nov 2011, 9:40 pm
• Defendants: Mylan Pharmaceuticals Inc.; Mylan Inc. [read post]
31 Oct 2011, 6:46 am
Lately, we've been thinking about generic pharmaceuticals and preemption. [read post]
28 Oct 2011, 7:00 am
Mylan Pharmaceuticals, Inc., 751 F. [read post]
26 Oct 2011, 2:30 am
– opinion on valuable patent life of a pharmaceutical product (The SPC Blog) EU: CJEU rules no patent protection for human embryonic stem cell-related inventions: Brüstle v Greenpeace (IPEG) (ipwars.com) (EPLAW) (IPBiz) (Patent Baristas) EU: CJEU says no to patents requiring the destruction of a human embryo – Brüstle v Greenpeace – an Australian perspective (IP Whiteboard) EU: Stem cell patent decision hurts science – Brüstle v Greenpeace (BIOtechNOW)… [read post]
21 Oct 2011, 7:40 am
Sepracor, now known as Sunovion Pharmaceuticals, requested the PTO to re-examine these patents, which now has been completed. [read post]
17 Oct 2011, 11:24 am
(Mylan) filed an action to try to invalidate a Supplementary Protection Certificate (“SPC”) for a drug for the treatment of Alzheimer’s disease called rivastigmine. [read post]
10 Oct 2011, 10:00 am
Teva, Ranbaxy Pharmaceuticals, Inc., Mylan Pharmaceutical Inc., and Barr Laboratories, Inc. - which Teva now owns - all have taken steps toward entering the market, and all are eligible to seek a 180-day marketing exclusivity provided under federal law. [read post]
21 Sep 2011, 6:41 am
Mylan Bertek Pharmaceuticals, Inc., Civil No. 09-690 (JNE/JSM), 2010 WL 2519988 (D. [read post]
21 Sep 2011, 2:36 am
USPTO (Patent Docs) US: Deciphering the patent-eligibility message in Prometheus, Myriad and Classen (Patent Docs) US: Biotech/pharma patent issuances increased 39% in 2010 (Patent Docs) Vietnam cables: Data exclusivity should be automatic, comprehensive, retroactive and without procedures and formalities (KEI) Products Actos (Pioglitazone) – US: Takeda files patent infringement complaint against Accord Healthcare in response to Para IV certification (Patent Docs) Atorvastatin –… [read post]
20 Sep 2011, 2:26 pm
In support, it cited Andrx Pharmaceuticals, Inc. v. [read post]
9 Sep 2011, 6:13 am
MYLAN FALSE CLAIMS ACT ALLEGEDLY MERITLESS As reported by the Pittsburgh Business Times, a False Claims Act lawsuit against Mylan Pharmaceuticals is allegedly “meritless” per the company. [read post]
8 Sep 2011, 12:59 pm
Government Bloomberg News reports that Par Pharmaceutical Cos., a maker and distributor of generic drugs, engaged in an illegal drug- switching scheme to increase sales, the U.S. said in a lawsuit in which two Mylan Inc. units are also accused by a whistleblower of wrongdoing. [read post]
7 Sep 2011, 9:59 pm
By James DeGiulio -- Teva's Patents Covering Copaxone Upheld in Infringement Suit Mylan failed in its efforts to dismiss Teva's patent suit over the multiple-sclerosis drug Copaxone when the patents directed to the active pharmaceutical ingredient (API) in the drug, glatiramer acetate, were upheld as valid. [read post]
7 Sep 2011, 4:22 am
Apotex (Patently-O) Glivec (Imatinib mesylate) – India: The Glivec patent saga – its raining recusals (Spicy IP) Glivec (Imatinib mesylate) – India: Supreme Court to hear Novartis challenge to India’s patent law (IP Watch) Lo Loestrin Fe (Norethindrone acetate / Ethinyl estradiol / Ferrous fumarate) – US: Warner Chilcott files patent infringement complaint against Lupin in response to Para IV certification (Patent Docs) Lumigan (Bimatoprost) – US: Allergan files… [read post]
6 Sep 2011, 11:24 pm
Mylan Pharmaceuticals, the makers of the controversial antidepressant Paxil, is trying to negotiate with the FDA as well as other generic drug manufacturers to pay an astonishing $299 million every year for the inspections of their foreign facilities — this according to reports by ABC News. [read post]
30 Aug 2011, 5:18 am
The Mylan case is Teva Pharmaceuticals Industries Ltd. v. [read post]
29 Aug 2011, 5:53 am
("Schering") filed a complaint alleging that Mylan Pharmaceuticals' ("Mylan") Abbreviated New Drug Application ("ANDA") infringed two of Schering's patents that disclosed different ways to reduce cholesterol levels. [read post]
27 Aug 2011, 7:55 pm
Mylan Labs., Inc., 464 F.3d 1286, 1289 (Fed. [read post]
25 Aug 2011, 5:58 am
A generic version of Amrix® (cyclobenzaprine extended-release) was released by Mylan pharmaceuticals on 05/13/2011. [read post]
24 Aug 2011, 12:33 am
USPTO (Patent Docs) US: ALJ Rogers sets procedural schedule in Certain Coenzyme Q10 (337-TA-790) (ITC 337 Law Blog) Products Actos (Pioglitazone) – Brazil: STJ rules against extension of patent related to Actos (IP tango) Frova (Frovatriptan) – US: Endo Pharmaceuticals files patent infringement complaint against Mylan in response to Para IV certification filing (Patent Docs) Gemzar (Gemcitabine) – US: ALJ Rogers grants motion to terminate investigation in… [read post]
